top
Search terms
Results 1 - 2 of 2 - ordered by :
Ehjournal

Abstract Aims VENTURE-AF is the first prospective randomized trial of uninterrupted rivaroxaban and vitamin K antagonists (VKAs) in patients with non-valvular atrial fibrillation (NVAF) undergoing ...

European Heart Journal, Cappato, Riccardo, Marchlinski, Francis E., Hohnloser, Stefan H., Naccarelli, Gerald V., Xiang, Jim, Wilber, David J., Ma, Chang-Sheng, Hess, Susanne, Wells, Darryl S., Juang, ...

Date : 21/07/2015 Item size : 303748 bytes
Ehjournal

Abstract Aims VENTURE-AF is the first prospective randomized trial of uninterrupted rivaroxaban and vitamin K antagonists (VKAs) in patients with non-valvular atrial fibrillation (NVAF) undergoing ...

European Heart Journal, Cappato, Riccardo, Marchlinski, Francis E., Hohnloser, Stefan H., Naccarelli, Gerald V., Xiang, Jim, Wilber, David J., Ma, Chang-Sheng, Hess, Susanne, Wells, Darryl S., Juang, ...

Date : 21/07/2015 Item size : 330013 bytes